معرفی
Dr. Pamela Nono Nankam serves as a Post-Doctoral Researcher at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München, located within the University Hospital Leipzig at the University of Leipzig's Faculty of Medicine. She leads research within Matthias Blüher's Clinical Obesity Research Group, focusing on translational approaches to metabolic disorders.
Her academic foundation includes:
- Bachelor and Master of Sciences in Animal Physiology from the University of Dschang, Cameroon
- PhD in Human Biology from the University of Cape Town, South Africa, supported by NRF-TWAS and DAAD fellowships
Dr. Nankam's research centers on adipose tissue dysfunction mechanisms, particularly in lipedema and obesity. She pioneers single-cell/nuclei investigations of human adipose tissue across diverse fat distributions, while identifying novel circulating biomarkers for early disease detection. Her work bridges basic science with clinical applications to develop personalized treatment frameworks.
Analysis of her recent publications reveals dominant themes in adipose tissue heterogeneity, with increasing focus on lipedema pathophysiology and ethnic-specific metabolic responses. The integration of single-cell sequencing with clinical phenotyping represents a significant methodological evolution in her research trajectory.
Her scientific contributions have earned recognition through:
- Science Prize Award of the Lipedema Society e.V. (2023)
- Proof of Concept Award from the Lipedema Foundation (2022)
- DAAD Research Grant for doctoral studies (2018)
- NRF-TWAS Doctoral Fellowship (2016)
Funding for her work includes an active grant from the Lipedema Foundation (USA) supporting biomarker discovery in lipedema. She maintains strategic collaborations through the German Lipedema Society and European Association for the Study of Diabetes, with research directly informing clinical practice improvements.
Within HI-MAG's infrastructure, she directs single-cell genomics workflows for adipose tissue characterization while contributing to the Clinical Obesity Research Group's mission of transforming diagnostic paradigms for metabolic disorders through mechanistic insights.
